of 3
Featured News
Some of the leading stories and synthetic biology information from SynbiCITE
21 Jul 2017
A vibrant synthetic biology ecosystem has developed in the UK – promising new jobs and valuable technology
A survey of synthetic biology company start-ups in the UK is published today by SynbiCITE, the UK’s national centre for the commercialisation of synthetic biology. The study reveals a vibrant ecosystem sustaining a thriving and rapidly growing sector of the bioeconomy.
17 Jul 2017
Bio-start Awards 2017
Bio-start awards over £100K in zero-equity prizes to 6 high-impact start-ups Bio-start celebrates UK innovative start-ups with commercial ideas that ...
UK Synthetic Biology start-up survey 2017
The UK’s first survey of the Synthetic Biology industry following a year of significant progress.
SynbiCITE’s UK Synthetic Biology start-up survey 2017 will assess the current and potential size of the Synthetic Biology industry, looking closely at growth trends, company scale, the value of the sector, key stakeholders and the commercial impact it could have. The challenges facing the industry, such as funding and IP protection, regulatory issues and ethics will also be evaluated. The completed report will be available this summer.
SynbiCITE has created a globally renowned national resource of interacting partners from academia, industry and business across the UK to accelerate the commercialisation of world-class science and emerging technologies encompassed by synthetic biology into new products, tools, processes and services.
Innovation, education & collaboration
Watch SynbiCITE's new film to get an insight into the potential that synthetic biology offers us all.
Synthetic biology is unlocking significant new opportunities for industries ranging from life sciences and specialty chemicals to bioenergy and waste remediation. By facilitating the creation of new tools and techniques, synbio has the potential to reshape many technologies to affect our lives positively and to reduce the impact that we have on our planet. Synbio is the engineering of biology and it’s already helping to make many businesses more effective, more productive and more environmentally friendly.
SynbiCITE has created a globally renowned national resource of interacting partners from academia, industry and business across the UK which accelerates the commercialisation of world-class science and the emerging technologies encompassed by synthetic biology and engineering biology into new products, tools, processes and services.
We partner with some of the world’s most forward-thinking organisations
We support our partners through events and training programmes including problems-solutions brokerage meetings. We provide funding of development projects including seed funding of Proof of Concept projects and follow-on funding of longer, larger projects for the development of prototypes and taking these on to pilot production scale manufacturing.
View our network
Synthetic Biology community
Take a look at the active and interactive synthetic biology community. Join the conversation and get involved.
Exploring #synbio through art - exhibition at @BrisSynBio's annual synthetic biology conference… https://t.co/aTNar02HeC
SynbiCITE
- 6
- 6
Soo Mei is excited to be presenting a poster for @SynbiCITE at the @bmss_official in Manchester #BMSS17… https://t.co/TqMO5aDukf
SynbiCITE
- 2
- 6
Congrats to Tim, Sean & team @ Synthace raised £7.3m https://t.co/cWlKNHVrUn via @SynbiCITE
Stephen Chambers
- 0
- 0
Synpromics expands facilities to meet demand for revolutionary gene control technology
Synpromics Ltd, the leader in gene control and synthetic promoter development, today moves to new world-class facilities at the Roslin Innovation Centre.
How a biofuel dream turned into a nightmare https://t.co/0QJd0Kre7p via @BostonGlobe
Stephen Chambers
- 3
- 2
Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs
The Company’s Antha operating system brings end-to-end digitization to biotechnology, replacing current artisanal methods of development Speaking...
Three upcoming Innovation Funding competitions through InnovateUK
InnovateUK, the UK’s innovation agency, has three forthcoming Innovation Funding Competitions that opened recently.
Great meeting with Hitachi R&D at Washington CORE https://t.co/6d6kQKIk3Y
Stephen Chambers
- 1
- 5
Ginkgo Bioworks, Bayer to Invest $100M in New Agbio Company #synbio https://t.co/GtQ3tNyR1R
Stephen Chambers
- 4
- 3
Looking ahead: Conference season has arrived
As the summer draws to a close, the life science sector once again gears up for conference season. Here we take a look at some events we are particularly excited about:
World leading DNA technology is expanding its operations in London as it grows to meet global DNA demand
Touchlight Genetics Ltd has developed a revolutionary DNA technology that can synthetically manufacture commercial scale DNA in a two-week process – a...